BioCentra Molecular Innovations' Debt - II Round

BioCentra Molecular Innovations raised a round of funding on August 11, 2015.

BioCentra is a biopharmaceutical technology and drug discovery company. The company makes low-cost generic biopharmaceutical products and provides cutting edge technologies accessible to drug companie…

Articles about BioCentra Molecular Innovations' Debt - II Round: